Miura Co Ltd TSE:6005 NM- IMI plc DB:IMI1 NM- GEA Group AG DB:G1A -9.1% IDEX Corporation DB:ID7 58.7% Dover Corporation DB:DOV NM- Sulzer AG SWX:SUN NM- Paul Mueller Co OTCPK:MUEL NM- Technotrans AG DB:TTR1 NM- AGES Industri AB OM:AGESB NM- Engcon AB OM:ENGCONB NM- ...
1436324 21-Substituted 3-hydroxy-pregnane compounds GLAXO LABORATORIES Ltd 11 May 1973 [12 May 1972] 22489/72 Heading C2U Novel steroids of the pregnane or 19- norpregnane series possess essentially a 3-hydroxy group, a 5-H atom or a #4-double bond, a 17-H atom, a 20-oxo group and...
资川生化科技(苏州)有限公司0512-66317708 13372112871huijuan@zitrans.cn中国177058 ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795ivan@atkchemical.com中国3302460 Watson Biotechnology Co.,Ltd+86-18186686046 +86-18186686046sales01@watsonbiotech.cn中国585058...
1434919 3-Hydroxy-steroids GLAXO LABORATORIES Ltd 15 June 1973 [15 June 1972] 28118/72 Heading C2U The invention comprises steroids of the androstane and 19-nor-androstane series possessa 3-hydroxy group, a 17-hydrogen atom and in position 17# as cyano, esterified carboxyl or mono- or di-...
1434919 3-Hydroxy-steroids GLAXO LABORATORIES Ltd 15 June 1973 [15 June 1972] 28118/72 Heading C2U The invention comprises steroids of the androstane and 19-nor-androstane series possessa 3-hydroxy group, a 17-hydrogen atom and in position 17# as cyano, esterified carboxyl or mono- or di-...
1317184 Injectable anaesthetics GLAXO LABORATORIES Ltd 11 June 1970 [20 June 1969] 31371/69 Heading A5B [Also in Division C2] Anaesthetic compositions suitable for use by parenteral administration comprise an aqueous solution containing at least 1mg/ml of 3- hydroxy-5-pregnane-11, 20-dione and ...
1436324 21-Substituted 3-hydroxy-pregnane compounds GLAXO LABORATORIES Ltd 11 May 1973 [12 May 1972] 22489/72 Heading C2U Novel steroids of the pregnane or 19- norpregnane series possess essentially a 3-hydroxy group, a 5-H atom or a #4-double bond, a 17-H atom, a 20-oxo group and...
Any 3-oxo group in the starting material is optionally protected, e.g. as a 3-methoxy- #2,5(10)-compound, in which case a deprotection. step must follow the metal hydride reduction. Compound Ib is alternatively prepared by acetylating the corresponding free 3#-ol. The preparation of ...
Any 3-oxo group in the starting material is optionally protected, e.g. as a 3-methoxy- #2,5(10)-compound, in which case a deprotection. step must follow the metal hydride reduction. Compound Ib is alternatively prepared by acetylating the corresponding free 3#-ol. The preparation of ...
in which the amino group is protected by forming an enamine with a #-dicarbonyl compound; removing the amino protecting group from the product; adding sufficient hydrazine or its derivative (e.g. semicarbazide) to prevent reaction of the liberated dicarbonyl compound; and, if desired de-esterif...